Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
IntroductionPROCEEDINGS OF THE 21st ANNUAL MEETING OF THE SOCIETY OF BIOTHERAPEUTIC APPROACHES

Preface

Takeo Fukushima
Anticancer Research July 2018, 38 (7) 4231;
Takeo Fukushima
President of the Society of Biotherapeutic Approaches (SBA)
Ph.D. & M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

This special issue of ANTICANCER RESEARCH presents the Proceedings of the 21st Annual Meeting of the Society of Biotherapeutic Approaches. It is our great pleasure to introduce this issue expressing my sincere gratitude to the Editors of Anticancer Research for kindly accepting and publishing the proceedings of our regional meeting in Japan in ANTICANCER RESEARCH.

The 21st meeting was held in Fukuoka, Japan on December 2, 2017, chaired by Prof. Shin'ichiro Yasunaga, Department of Biochemistry, Faculty of Medicine, Fukuoka, Japan and Dr. Takashi Morisaki, Fukuoka Cancer General Clinic, Fukuoka, Japan. One of the highlights in this conference was the special lecture on “Therapeutic potential of onco-immunotherapy: care or cure?” presented by Prof. Yoshikazu Yonemitsu, R&D Laboratory for Innovative Biotherapeutics Science, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan. In addition, there were four workshops and many oral presentations on a wide range of basic and clinical topics, offering impressive advances in this field.

The main aims of our Society are to facilitate good communication between basic researchers and clinicians, and to perform clinical trials with adequate informed consent in an appropriate and professional manner. These aspects include important issues for the progress of biotherapy as well as for medicine in general. It is our sincere hope that these Proceedings will contribute to further progress in the field of biotherapy and that our members will continue to foster the aims of our Society.

  • Copyright© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 38, Issue 7
July 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Preface
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Preface
Takeo Fukushima
Anticancer Research Jul 2018, 38 (7) 4231;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Preface
Takeo Fukushima
Anticancer Research Jul 2018, 38 (7) 4231;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Improvement in Protracted Wound Healing by Topical Cream Containing Lipopolysaccharide Derived from Pantoea agglomerans
  • Association of Serum HB-EGF Value and Response to Chemotherapy in Patients with Recurrent Ovarian Cancer
  • Phagocytic Activation of Macrophages with Serum MAF Depends on Engulfment Efficiency and Not Migratory Activity
Show more PROCEEDINGS OF THE 21st ANNUAL MEETING OF THE SOCIETY OF BIOTHERAPEUTIC APPROACHES
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire